Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abiomed
MedTech
FDA opens use of J&J's Impella heart pumps to pediatric patients
The agency expanded its previous approvals for the Impella 5.5 and CP pumps for children weighing at least 30 kg and 52 kg, respectively.
Conor Hale
Dec 12, 2024 2:30pm
TCT: Abiomed clears pivotal study for shrinkable heart pump
Oct 30, 2024 9:00am
J&J CEO says M&A strategy to 'continue' after medtech megadeals
Apr 16, 2024 1:42pm
J&J's Abiomed pump reduces deaths after widowmaker heart attacks
Apr 8, 2024 12:12pm
J&J's Abiomed sees serious Impella recall linked to 49 deaths
Mar 21, 2024 2:29pm
J&J highlights Abiomed’s first year in 2023 medtech earnings
Jan 23, 2024 12:53pm
